Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,159 | -4,401 | -2,119 | -6,732 | -5,271 |
| Depreciation Amortization | 18 | 11 | 8 | 66 | 53 |
| Other Working Capital | 159 | 518 | 627 | -188 | -139 |
| Other Operating Activity | 879 | 225 | 118 | 490 | 352 |
| Operating Cash Flow | $-6,102 | $-3,648 | $-1,367 | $-6,364 | $-5,005 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-60 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,400 | 2,400 |
| Common Stock Issued | 13,942 | 1,510 | N/A | N/A | N/A |
| Other Financing Activity | -135 | -89 | -42 | 6,049 | 1,448 |
| Financing Cash Flow | $13,807 | $1,422 | $-42 | $8,449 | $3,848 |
| Beginning Cash Position | 6,166 | 6,166 | 6,166 | 4,081 | 4,081 |
| End Cash Position | 13,811 | 3,941 | 4,758 | 6,166 | 2,924 |
| Net Cash Flow | $7,645 | $-2,226 | $-1,408 | $2,086 | $-1,157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,102 | -3,648 | -1,367 | -6,364 | -5,005 |
| Capital Expenditure | -60 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -6,162 | -3,648 | -1,367 | -6,364 | -5,005 |